L1CAM expression is a marker of poor prognosis, short recurrence-free survival and advanced stage of the disease in many cancers including endometrial, ovarian carcinomas, pancreatic ductal adenocarcinoma melanoma and glioblastoma [23, 42]. Here, L1CAM is linked to ovarian carcinoma.